Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

James Don Murphy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0523-9091; OpenAlex author ID A5064099533. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 4, last author 5)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2012: 3 papers · 2013: 1 paper · 2014: 1 trial · 2015: 2 papers · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers

Papers 13

  1. Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer. Last author DOI 10.1016/j.ijrobp.2021.02.008↗
  2. Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer. Last author DOI 10.1200/cci.20.00137↗
  3. The Landmark Series: Locally Advanced Pancreatic Cancer and Ablative Therapy Options. First author DOI 10.1245/s10434-021-09662-z↗
  4. Intrafractional relationship changes between an external breathing signal and fiducial marker positions in pancreatic cancer patients. Co-author DOI 10.1002/acm2.12841↗
  5. A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis. Last author DOI 10.6004/jnccn.2018.7111↗
  6. Automatic patient positioning and gating window settings in respiratory-gated stereotactic body radiation therapy for pancreatic cancer using fluoroscopic imag… Co-author DOI 10.1002/acm2.12258↗
  7. Clinical Impact of Local Progression in Pancreatic Cancer. Last author DOI 10.6004/jnccn.2018.7013↗
  8. Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Last author DOI 10.1016/j.meddos.2015.04.002↗
  9. Approach to patients with pancreatic cancer without detectable metastases. First author DOI 10.1200/jco.2014.59.7930↗
  10. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer. First author DOI 10.1016/j.ijrobp.2012.07.2366↗
  11. Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Co-author DOI 10.1002/cncr.26365↗
  12. Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2011.08.022↗
  13. Intensity-modulated radiotherapy for pancreatic adenocarcinoma. First author DOI 10.1016/j.ijrobp.2011.09.035↗

Trials 1

  1. Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer Principal investigator NCT02454140↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 3 shared papers, 2015–2021 · strength 0.35
  2. Laura Cerviño · 2 shared papers, 2018–2020 · strength 0.24
  3. Niclas Pettersson · 2 shared papers, 2018–2020 · strength 0.24
  4. Rebekah Ruth White · 1 shared paper, 2021 · strength 0.22
  5. Robert C.G. Martin · 1 shared paper, 2021 · strength 0.22
  6. Reith Roy Sarkar · 2 shared papers, 2018–2019 · strength 0.20
  7. Qinyu Chen · 1 shared paper, 2021 · strength 0.14
  8. P.T. Courtney · 1 shared paper, 2021 · strength 0.13
  9. Albert C. Koong · 3 shared papers, 2012–2013 · strength 0.10
  10. Daniel Tandel Chang · 3 shared papers, 2012–2013 · strength 0.10
  11. Nicholas Cardillo · 1 shared paper, 2018 · strength 0.09
  12. Gregory M. Heestand · 1 shared paper, 2015 · strength 0.08
  13. J.A. Abelson · 2 shared papers, 2012 · strength 0.06
  14. Yongbao Li · 1 shared paper, 2015 · strength 0.04
  15. Cullen M. Taniguchi · 1 shared paper, 2013 · strength 0.03
  16. Theodore Steven Lawrence · 1 shared paper, 2012 · strength 0.03
  17. Klaudia Urbaniak Hunter · 1 shared paper, 2012 · strength 0.03
  18. Edgar Ben‐Josef · 1 shared paper, 2012 · strength 0.03
  19. Isaac R. Francis · 1 shared paper, 2012 · strength 0.03
  20. Mark M. Zalupski · 1 shared paper, 2012 · strength 0.03
  21. George A. Poultsides · 1 shared paper, 2012 · strength 0.03
  22. James M. Ford · 1 shared paper, 2012 · strength 0.03
  23. Brendan Christopher Visser · 1 shared paper, 2012 · strength 0.03
  24. Pamela L. Kunz · 1 shared paper, 2012 · strength 0.03
  25. Jeffrey Allen Norton · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.